Noxopharm (ASX: NOX) provides to the market the Noxopharm and Nyrada Inc corporate presentations ahead of the TechKnow Invest Roadshow 2019 in Sydney (October 22, 2019) and Melbourne (October 24, 2019).
The Noxopharm presentation focuses on recently reported significant anti-cancer responses in the Company’s DARRT program in prostate cancer, and the commercial opportunity on offer.
For more information, download the attached PDF.
Download this document
